PET/CT with (124)I-cG250: great potential and some open questions.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 25055257.
- Also identified by DOI 10.2214/AJR.14.12490.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A novel PET radiotracer, (124)I-cG250, is currently under clinical investigation to distinguish clear cell renal cell carcinoma from other benign and malignant renal masses. In this article, we will make suggestions on the data needed to maximize the use of this radiotracer. Although the published data are promising, further data are needed to assess the potential usefulness of this agent when dealing with indeterminate renal masses.
Medical subject headings
- Antibodies, Monoclonal
- Carcinoma, Renal Cell
- Iodine Radioisotopes
- Kidney Neoplasms
- Multimodal Imaging
- Positron-Emission Tomography
- Tomography, X-Ray Computed